Ivermectin Will be Used as an Outpatient Treatment Option for COVID-19 Patients.

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational [Patient Registry]
SUMMARY

Ivermectin is currently being utilized by a number of physicians in the local area. My objective will be to enroll these patients at the time of their evaluation for COVID-19 infection and to follow their progress through their recovery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Maximum Age: 110
Healthy Volunteers: Accepts Healthy Volunteers
View:

• Between the ages of 12-110 years old

• Has a recently completed COVID test

• Symptomatic and seeking treatment

• Willingness to participate and have follow-up

• Able and willing to take medications and treatment suggestions from the physician

Locations
United States
Florida
Patrick Robinson MD LLC
Recruiting
San Antonio
Contact Information
Primary
Patrick R Robinson, MD
mustang6374@yahoo.com
3862377150
Backup
Dana M Robinson, RN
dmvkar143@gmail.com
8132156247
Time Frame
Start Date: May 1, 2022
Estimated Completion Date: May 1, 2024
Participants
Target number of participants: 1000
Treatments
COVID-19 patients treated with Ivermectin
This group of patients will be those who requested to be treated with Ivermectin and whom have been prescribed such by different physicians. This group may or may not include those treated with Monoclonal Antibodies or Remdesivir.
COVID-19 patients declining Ivermectin and wanting traditional treatment
This group of patients will be those who do not request to be treated with Ivermerctin and who want to be treated with a more traditional, minimalist approach. This group may or may not include those treated with Monoclonal Antibodies or Remdesivir.
Authors
Patrick r Robinson, Dana M Robinson
Sponsors
Leads: Patrick Robinson

This content was sourced from clinicaltrials.gov